JNJ (Johnson & Johnson) Float Percentage Of Total Shares Outstanding: 89.85% (As of Jul. 02, 2026)


JNJ Johnson & Johnson JNJ
85 GF Score
Price $263.04
GF Value $190.78
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Float Percentage Of Total Shares Outstanding?

Johnson & Johnson JNJ +3.57% 85 Float Percentage Of Total Shares Outstanding is 89.85% as of Jul. 02, 2026. GuruFocus rates JNJ with a GF Score™ of 85/100 and a GF Value™ of $190.78 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Johnson & Johnson's float shares is 2,162.87 Mil. Johnson & Johnson's total shares outstanding is 2,407.22 Mil. Johnson & Johnson's float percentage of total shares outstanding is 89.85%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Johnson & Johnson's Insider Ownership is 0.19%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Johnson & Johnson's Institutional Ownership is 83.82%.

JNJ
85GF Score
Johnson & Johnson JNJ
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Johnson & Johnson's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=2,162.87/2,407.22
=89.85%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 89.85% mean?
Johnson & Johnson (JNJ) has a Float Percentage Of Total Shares Outstanding of 89.85% as of Jul. 02, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Johnson & Johnson and its competitors.
Is Johnson & Johnson's Float Percentage Of Total Shares Outstanding too high?
Johnson & Johnson's current Float Percentage Of Total Shares Outstanding is 89.85%. Overall, Johnson & Johnson has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Float Percentage Of Total Shares Outstanding compare to ABBV and MRK?
Johnson & Johnson's Float Percentage Of Total Shares Outstanding of 89.85% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Johnson & Johnson and its competitors. Johnson & Johnson's current Float Percentage Of Total Shares Outstanding is 89.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Based on GuruFocus' analysis, Johnson & Johnson (JNJ) is currently considered Significantly Overvalued. The stock's GF Value™ is $190.78, compared to a current price of $263.04 — trading 37.9% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 89.85%. Johnson & Johnson's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Johnson & Johnson (JNJ), the current Float Percentage Of Total Shares Outstanding is 89.85% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of $263.04 is trading 37.9% above its estimated GF Value™ of $190.78. GuruFocus considers Johnson & Johnson to be Significantly Overvalued.

Key valuation signals for JNJ:

  • Float Percentage Of Total Shares Outstanding: 89.85%
  • GF Value™: $190.78 vs. price of $263.04 (37.9% above fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
85GF Score

Get the complete analysis for JNJ

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$263.04
Price
$190.78
GF Value